Cansativa GmbH, a German cannabis distribution and wholesaler, has become the first European company to import Latin American medical cannabis samples for initial testing.
Founded in 2017, Cansativa is a GDP-certified pharmaceutical wholesaler licensed for trade in controlled substances and headquartered in Frankfurt am Main, Germany. Cansativa is committed to the goal of professionalizing the medical cannabis market, eliminating stigmatization surrounding it, and reducing prices for patients.
Since the very beginning, Cansativa has operated its own distribution and fulfillment center, and as one of the “first movers” in the industry, it has become one of the largest importers and distributors of medical cannabis in Germany. From its location in Frankfurt am Main, the company supplies pharmacies and pharmaceutical wholesalers throughout Germany.
Initial Sample Testing Process
The samples will be provided by Clever Leaves, a leading vertically integrated licensed producer of medical cannabis in Colombia, and Fotmer Life Sciences, a leading licensed medical cannabis producer in Uruguay.
Clever Leaves, founder in 2016, is cultivating medical cannabis in the first phase of a 1.5 million square feet agricultural production facility which is compliant with Good Agricultural and Collection Practices (“GACP”). The Company began operating an EU Good Manufacturing Practices (“EUGMP”)-compliant extraction laboratory in November 2018 which anticipates securing EUGMP certification in late 2019.
Clever and Fotmer will provide several different flower and extract products which will then be tested by independent German laboratories for a number of properties, including but not limited to, microbiology, dry loss, assay, pesticides, heavy metal, aflatoxin, and ochratoxin. Following the approval of German and European standards for medical products, Clever Leaves and Fotmer, will work to demonstrate their ability to cultivate high-quality pharmaceutical-grade cannabis for future European commercialization.
To learn more Cansativa, click here.
Don’t miss out on the latest cannabis startup news, subscribe today.